» Articles » PMID: 27825089

MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting P53/Nanog

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Nov 9
PMID 27825089
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Selected markers of ovarian cancer and their relation to targeted therapy (Review).

Markowska A, Kojs Z, Twardawa D, Pietras J, Markowska J Exp Ther Med. 2024; 27(5):236.

PMID: 38628658 PMC: 11019661. DOI: 10.3892/etm.2024.12523.


Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.

Wilczynski J, Wilczynski M, Paradowska E Int J Mol Sci. 2022; 23(5).

PMID: 35269636 PMC: 8910575. DOI: 10.3390/ijms23052496.


Efficient miRNA Inhibitor Delivery with Graphene Oxide-Polyethylenimine to Inhibit Oral Squamous Cell Carcinoma.

Ou L, Sun T, Liu M, Zhang Y, Zhou Z, Zhan X Int J Nanomedicine. 2020; 15:1569-1583.

PMID: 32210552 PMC: 7069571. DOI: 10.2147/IJN.S220057.


miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).

Zhang P, Zhu J, Zheng Y, Zhang H, Sun H, Gao S Am J Transl Res. 2019; 11(7):4151-4165.

PMID: 31396325 PMC: 6684900.


Role of Epigenetics in Uveal Melanoma.

Li Y, Jia R, Ge S Int J Biol Sci. 2017; 13(4):426-433.

PMID: 28529451 PMC: 5436563. DOI: 10.7150/ijbs.18331.